Skip to main content
Fig. 4 | Journal of Medical Case Reports

Fig. 4

From: Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report

Fig. 4

Thin-slice CT before and after the administration of lorlatinib. Compared with the patient’s condition before the administration of lorlatinib (a), SD has been maintained 33 months after the start of lorlatinib (b), and no recurrence of DILD has been observed. CT computed tomography, SD stable disease, DILD drug-induced interstitial lung disease

Back to article page

Journal of Medical Case Reports

ISSN: 1752-1947